Literature DB >> 12762957

Complications of pediatric and adolescent type 1 diabetes mellitus.

S J Brink1.   

Abstract

Type 1 diabetes mellitus is potentially associated with serious microvascular and macrovascular complications, although these are usually subclinical during the pediatric and adolescent years. There is no "grace" period for the beginnings of such complications. Duration of diabetes, glycemic control, age, and pubertal stage are critical factors contributing toward development of such problems. Other risk factors include family history (genetic predisposition), hyperlipidemia, hypertension, and smoking. The Diabetes Control and Complications Trial (DCCT) proved the importance of glycemic control and emphasized the ability of improved glucose control to prevent or decrease retinopathy, nephropathy, and neuropathy using a multidisciplinary same-philosophy-of-care approach plus targeted glucose and hemoglobin A(1c) values. Other natural history and intervention studies support the findings of the DCCT. Although our current tools are not perfect, they allow us to decrease microangiopathic complications very significantly if we educate our patients and their family members. Metabolic control counts.

Entities:  

Mesh:

Year:  2001        PMID: 12762957     DOI: 10.1007/s11892-001-0010-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  62 in total

Review 1.  Hypoglycaemia in children and adolescents with Type 1 diabetes mellitus.

Authors:  S J Brink
Journal:  Diabetes Nutr Metab       Date:  1999-04

2.  Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

Authors:  A S Krolewski; M Canessa; J H Warram; L M Laffel; A R Christlieb; W C Knowler; L I Rand
Journal:  N Engl J Med       Date:  1988-01-21       Impact factor: 91.245

3.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

4.  What level of HbA1c can be achieved in young diabetic patients beyond the honeymoon period?

Authors:  H Dorchy
Journal:  Diabetes Care       Date:  1993-09       Impact factor: 19.112

5.  Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls.

Authors:  K Kjaer; C Hagen; S H Sandø; O Eshøj
Journal:  J Clin Endocrinol Metab       Date:  1992-08       Impact factor: 5.958

6.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

7.  [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].

Authors:  H Dorchy
Journal:  Arch Pediatr       Date:  1994-11       Impact factor: 1.180

8.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

Authors:  N H White; D A Skor; P E Cryer; L A Levandoski; D M Bier; J V Santiago
Journal:  N Engl J Med       Date:  1983-03-03       Impact factor: 91.245

9.  Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study.

Authors:  W Burger; G Hövener; R Düsterhus; R Hartmann; B Weber
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

10.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  7 in total

1.  Technology Use for Diabetes Problem Solving in Adolescents with Type 1 Diabetes: Relationship to Glycemic Control.

Authors:  Yaa A Kumah-Crystal; Korey K Hood; Yu-Xian Ho; Cindy K Lybarger; Brendan H O'Connor; Russell L Rothman; Shelagh A Mulvaney
Journal:  Diabetes Technol Ther       Date:  2015-03-31       Impact factor: 6.118

2.  The Diabetes-Specific Risk-Taking Inventory: Piloting a New Measure for Adolescents With Type 1 Diabetes.

Authors:  Rachel M Wasserman; David D Schwartz; Barbara J Anderson
Journal:  Diabetes Spectr       Date:  2021-06-03

3.  Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes.

Authors:  Ronnie Aronson; Peter A Gottlieb; Jens S Christiansen; Thomas W Donner; Emanuele Bosi; Bruce W Bode; Paolo Pozzilli
Journal:  Diabetes Care       Date:  2014-07-10       Impact factor: 19.112

Review 4.  Diabetic nephropathy in children and adolescents.

Authors:  Radovan Bogdanović
Journal:  Pediatr Nephrol       Date:  2007-10-17       Impact factor: 3.714

5.  Impact of Socioeconomic Characteristics on Metabolic Control in Children with Type 1 Diabetes in a Developing Country

Authors:  Abeer Alassaf; Rasha Odeh; Lubna Gharaibeh; Sarah Ibrahim; Kamel Ajlouni
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-04-17

6.  Effects of circadian blood pressure patterns on development of microvascular complications in pediatric patients with type 1 diabetes mellitus.

Authors:  Jeong-Seon Lee; Yun Jeong Lee; Young Ah Lee; Choong Ho Shin
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-01-17

7.  Knowledge of carbohydrate counting and insulin dose calculations among hospital staff in a regional general paediatrics unit.

Authors:  Jennifer R O'Gorman; Orla O'Leary; Natalie Finner; Anne Quinn; Clodagh S O'Gorman
Journal:  Springerplus       Date:  2015-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.